23 articles · page 2 of 2 · showing 13 to 23
Outer Biosciences uses living human skin and machine learning to discover new cosmetic ingredients, keeping tissue viable for up to four weeks in the lab.
Moderna and Merck say their personalised mRNA cancer therapy met key Phase 3 goals in melanoma, reducing the risk of recurrence and distant metastasis.
Vivodyne opened a human biological data centre with 12 robotic HIVE labs designed to generate large-scale human tissue data for AI drug discovery research.
Science Corporation has secured European regulatory approval for its PRIMA vision-restoring implant, bringing the brain-computer interface technology closer to commercial use for patients…
Dimension Capital has raised an $800 million third fund, expanding its investment strategy focused on AI, biotechnology and deep technology startups.
Colossal Biosciences is reportedly seeking fresh funding at a valuation of $20 billion to $30 billion as the de-extinction startup expands its biotechnology, AI and conservation businesses.
OpenAI researcher Miles Wang is reportedly leaving the company to launch an AI drug discovery startup, with funding talks valuing the venture at about $2 billion.
Anthropic introduces Claude Science, a research workbench that helps scientists manage workflows, analyse data, and accelerate discoveries using existing Claude AI models.
Imperagen has raised £5 million to combine quantum physics and artificial intelligence for enzyme engineering, accelerating biotechnology research and industrial innovation.
Cauldron Ferm is turning microbes into nonstop production systems, enabling scalable, cost-efficient biomanufacturing across multiple industries.
AI-driven drug discovery startup Converge Bio has raised a $25 million Series A round led by Bessemer Venture Partners to accelerate pharmaceutical research using generative models trained…
